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While obesity represents one of several risk factors
for colorectal cancer in humans, the mechanistic
underpinnings of this association remain unresolved.
Environmental stimuli, including diet, can alter the
epigenetic landscape of DNA cis-regulatory ele-
ments affecting gene expression and phenotype.
Here, we explored the impact of diet and obesity on
gene expression and the enhancer landscape in
murine colonic epithelium. Obesity led to the accu-
mulation of histone modifications associated with
active enhancers at genomic loci downstream of
signaling pathways integral to the initiation and pro-
gression of colon cancer. Meanwhile, colon-specific
enhancers lost the same histone mark, poising cells
for loss of differentiation. These alterations reflect a
transcriptional program with many features shared
with the program driving colon cancer progression.
The interrogation of enhancer alterations by diet in
colonic epithelium provides insights into the biology
underlying high-fat diet and obesity as risk factors for
colon cancer.
INTRODUCTION
Colorectal cancer (CRC) is the third most common human can-
cer worldwide, with more than 1 million new cases every year
(Ferlay et al., 2010). Above normal body weight and obesity are
among the principal risk factors for development of colorectal
cancer in human populations as well as in animal models (Lars-
son and Wolk, 2006; Moghaddam et al., 2007; Reddy et al.,
1977; Wasan et al., 1997). In humans, the relationship between
obesity and colorectal cancer incidence appears to be modified
by gender. In men, incidence of colorectal cancer is increased in
the obese; in women, this association is weaker (Bardou et al.,
2013). While several hypotheses rationalize the link between
obesity and colorectal cancer, it seems likely that contributing
factors are complex.702 Cell Metabolism 19, 702–711, April 1, 2014 ª2014 Elsevier Inc.To explore the effects of Western diet, weight gain, and
obesity on the epigenomic landscape of colonic epithelial cells,
we employed a mouse model of diet-induced obesity. C57BL/
6 mice were fed a diet wherein either 10% of calories (LF)
or 60% of calories (HF) come from fat. To globally map alter-
ations of the epigenomic landscape induced by high-fat diet
and obesity, we performed chromatin immunoprecipitation
sequencing (ChIP-seq) analysis of histone H3 lysine 27 acet-
ylation (H3K27ac). Our study revealed striking alterations in
enhancer utilization, consistent with a dietary predisposition to
cancer.
RESULTS
Acetylation of H3K27 as an Indicator of Chromatin
Landscape Changes
To assess the impact of diet and gender on the epigenome in
colonic epithelia, male and female C57BL/6 mice were raised
on low-fat (10%of calories from fat) and high-fat (60%of calories
from fat) diets for periods of 15–20 weeks. Colonic epithelial
cells were harvested using a well-established protocol (Roediger
and Truelove, 1979) to generate RNA and chromatin. Tran-
script abundance was determined by conventional microarray;
chromatin was evaluated by ChIP for H3K27ac. Analyses were
performed on biological replicate animals (two replicates per
dietary regimen for females, three replicates per dietary regimen
for males).
Local enrichment of H3K27ac was determined using standard
peak calling; this analysis revealed40,000 significant H3K27ac
peaks in each diet group at a false discovery rate of less than
0.001. H3K27ac peaks showed a significant overlap (75%–
91% of peaks) across biological replicates regardless of gender
(Table S1A available online). The distribution of H3K27ac relative
to annotated genes was similar among groups, regardless of diet
or gender, with peaks mapping to intragenic (43%), intergenic
(30%), and promoter regions (±1 kb around the transcription
start site [TSS], 24%) (Table S1B). Chromatin-state models
predict a correlation between H3K27ac proximal to the tran-
scription start site and gene expression (Ernst et al., 2011). We
determined the relationship between transcript abundance and
H3K27ac level in a 2 kb window centered on the transcription
Figure 1. High-Fat Diet Changes the Enhancer Landscape in Colonic Epithelium
(A) The heatmap depicts H3K27ac levels at differentially enriched H3K27ac regions (female mice) extending 5 kb from the midpoint of the regions. The images
were generated using Partek Genomics Suite v.6.11.0321 based on normalized counts of H3K27ac ChIP-seq fragment using 250 bp bins. Read counts were
normalized by millions of uniquely mapped, nonduplicate reads, and fragment centers were estimated to be 100 nt downstream of the 50 mapping location.
(B) UCSC genome browser views illustrating representative examples of gained H3K27ac region (top panel) and lost H3K27ac region (bottom panel) in wild-type
mice.
(C) Gained and lost H3K27ac regions were mapped to the closest RefSeq gene TSS, and the distribution of distance relative to the nearest TSS is shown.
(D) Percent of gained and lost H3K27ac regions overlapping with each ENCODE enhancer mark. See also Figure S1 and Table S1.
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concluded that the H3K27ac ChIP-seq data were of sufficient
quality to support detailed analysis.
High-Fat Diet Induces Changes in the Enhancer
Landscape of Colonic Epithelium
A statistical method (http://www.bioconductor.org/packages/
release/bioc/html/DiffBind.html), which detects differential
binding sites consistently changed in biological replicates,
comparing groups identified 876 regions that gained acetylation
at H3K27 and 691 regions that lost this mark in females as a
function of diet (Figure 1A); 231 regions gained H3K27ac, and
1,238 regions lost H3K27ac in males (Figure S1A). A subset of
these differentially acetylated regions was validated by ChIP-CqPCR (Figure S1C). Exemplar loci for each category were
depicted in Figure 1B. Differentially enriched H3K27ac regions
predominantly localized outside known promoters (>2 kb
away from the nearest TSS) (Figure 1C), at regions that are
moderately conserved across placental mammals (Figure S1B)
and overlap ENCODE marks (H3K4me1, H3K27ac, and DNase
HS) (Figure 1D), suggesting that they function as enhancers.
We tested this prediction using luciferase reporter assays,
finding detectable enhancer activity in 10 of 11 regions tested
(Figure S1D).
Direct overlap of differentially acetylated loci was very infre-
quent across gender, occurring less than 5% of the time. As
individual promoters are frequently regulated by multiple en-
hancers (Thurman et al., 2012), we wondered whether genderell Metabolism 19, 702–711, April 1, 2014 ª2014 Elsevier Inc. 703
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pacting the same promoter by influencing different enhancers.
We tested this hypothesis by asking whether differentially acet-
ylated loci were colocalized in genomic space, consistent with
the distances between promoter and enhancer defined by cur-
rent models (Dixon et al., 2012; Sanyal et al., 2012). A statistically
significant majority of regions either gaining acetylation in males
(126 of 231, p < 0.0001, Fisher’s exact test) or losing acetylation
in females (376 of 691, p = 0.0015, Fisher’s exact test) was local-
ized within a genomic interval consistent with this hypothesis
(Table S1D).
Diet Reprograms the Enhancer Landscape to Resemble
Colon Cancer
A recent report describing the enhancer landscape of human
colon cancer concluded that cis-acting regulatory DNA with
decreased levels of histone marks prototypical of enhancers in
tumor versus normal tissue were enriched in loci with specific
functions in intestinal crypts. Conversely, loci with elevated
levels of enhancer marks in the same comparison were not en-
riched in any tissue-specific pattern (Akhtar-Zaidi et al., 2012),
supporting the conclusion that the tumor enhancer landscape
reflects a loss of differentiated status. Given the association of
obesity with elevated risk of colorectal cancer, we hypothesized
that dietary fat and/or obesity might remodel the enhancer land-
scape of colonic epithelium to resemble the cancer enhancer
profile. To test this hypothesis, we assessed the tissue speci-
ficity of differentially acetylated (H3K27ac) regions using a
function of Shannon entropy (Schug et al., 2005), as employed
previously (Akhtar-Zaidi et al., 2012), to rank these regions in
order of their specificity in colon and nine other tissue types.
Loci losing H3K27ac were enriched in colon-specific acetylated
loci, whereas regions gaining H3K27ac were noncolon specific
regardless of gender (Figure 2A). These observations suggest
that high-fat diet and obesity prompt colonic epithelial cells to
remodel their enhancer landscape in a manner analogous to
the remodeling of the enhancer signature associated with colo-
rectal cancer.
To decipher the mechanism underlying enhancer reprogram-
ming, we used the HOMER de novo motif algorithm (Heinz
et al., 2010) to discover enriched transcription factor motifs at
differentially acetylated regions. The most significantly enriched
motifs (Figure 2B) exhibited striking concordance across gender,
suggesting mechanistic similarities in the biological response to
diet. Differential H3K27ac loci were enriched for binding sites of
transcription factors downstream of two pathways commonly
disrupted in colon cancer (Cancer Genome Atlas Network,
2012)—ETS (RAS signaling pathway) and Foxo1 (phosphatidyli-
nositol 3-kinase [PI3K] signaling pathway)—and AP1 (JNK
signaling pathway), which regulates cell proliferation and differ-
entiation in response to a variety of growth factors and cytokines
(Hess et al., 2004). To assess the significance of enrichment ofFigure 2. Diet-Induced Enhancer Alterations in Colonic Epithelium Res
(A) Tissue specificity of differentially enriched H3K27ac regions. Tissue specific
plotted for gained (left panels) and lost (right panels) H3K27ac regions in female
(B) De novo discovery of motifs associated with differential H3K27ac regions. The
The motifs were then assigned to transcription factors or transcription factor fam
H3K27ac regions containing the motifs and the p value for the overrepresentatio
Cthe RAS signaling pathway, a constitutively active KRAS
(G12V) allele was introduced into a mouse colon epithelial cell
line (CMT-93, wild-type for Kras), and a subset of regions that
contain putative ETS binding sites were assessed by ChIP-
PCR (Figure S2A). The resulting acetylation changes at these
loci closely parallel those observed in the ChIP-seq experiment,
suggesting that KRAS activation, presumably acting through
an ETS family transcription factor(s), could be responsible for a
subset of the H3K27ac alterations.
Binding sites of transcription factors essential for colon devel-
opment and differentiation were also enriched, including Cdx2,
Hnf4a, and Klf4 (Cattin et al., 2009; Gao et al., 2009; Garrison
et al., 2006; Ghaleb et al., 2011; Hryniuk et al., 2012; Katz
et al., 2002; Verzi et al., 2010). To interrogate the significance
of this finding, we compared our data to published ChIP-seq
data for Cdx2 and Hnf4a in small intestine (Verzi et al., 2011,
2013). Hnf4a peaks colocalized with diet-specific differentially
acetylated loci containing putative Hnf4a binding motif at high
frequency in females (81% of expected) and a reasonable fre-
quency in males (39% of expected). Cdx2 peaks in small intes-
tine overlapped with diet-specific differentially acetylated loci
in colon containing Cdx2 motif with lower frequency in males
(Table S2A). These findings are consistent with the hypothesis
that diet-specific differential acetylation may reflect alterations
in the maintenance of normal colon homeostasis.
We then investigated the biological functions of the differen-
tially enriched H3K27ac regions (Table S2) using the Genomic
Regions Enrichment of Annotations Tool (GREAT) (McLean
et al., 2010). Gained H3K27ac regions in females were en-
riched in genes involved in regulation of protein kinase activity
(mitogen-activated protein [MAP] kinase and JAK), EGFR- and
interleukin-6 (IL-6)-mediated signaling events, presenilin action
in Notch and Wnt signaling, and pathways controlling cell
adhesion and cell migration (a6b1 and a6b4 integrin signaling
pathways) (Giancotti and Ruoslahti, 1999). Strikingly, among en-
riched disease ontology terms, the most enriched terms were
colon cancer and diseases known to be correlated with a high-
fat diet, such as type 2 diabetes and hyperlipidemia. In addition,
gained H3K27ac regions were also significantly enriched with
genes upregulated by activated KRAS and with genes upregu-
lated inmetastatic, compared with nonmetastatic, tumors (Table
S2B). Lost H3K27ac regions in females were associated with
genes integral to antigen presentation (Table S2C), suggesting
that the colonic epithelial cells from mice on a high-fat diet
may be impaired in this function. In addition, lost H3K27ac re-
gions also associated with genes downregulated by activated
KRAS (Table S2C).
In keeping with the hypothesis that diet impacts similar
genes in males and females, the GREAT analysis of differential
H3K27ac regions in male mice revealed biological functions
similar to those observed in females (Table S2). These included
regulation of kinase activity, growth factor signaling (includingemble the Enhancer Signature of Colon Cancer
ity scores (Q-statistic, y axis) for H3K27ac signals in ten different tissues are
mice (upper panels) and male mice (lower panels).
HOMER package (v.4.1) was used to search for de novo DNA sequencemotifs.
ilies based on similarity with known motif matrices. In addition, the fraction of
n of each motif were shown. See also Figure S2 and Table S2.
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IL-6-mediated signaling events. In the disease ontology cate-
gory, tumor-related terms were also enriched. These results un-
derscore the similarities in the biological response to diet and
obesity in male and female mice.
However, human studies suggest gender-specific differences
in the relationship between obesity and cancer. In our genomic
regions enrichment analysis, we observed several enriched
pathways and terms that were unique tomalemice. Inmales, dif-
ferential H3K27ac regions were correlated with the RAC1 and
RhoA signaling pathways involved in cytoskeletal reorganization,
cellular adhesion, and cellular movement (Moorman et al., 1999).
Stem cell-related terms were also enriched in males, including
stem cell maintenance, stem cell development, and stem cell dif-
ferentiation (Table S2D). Thus, gender modifies the remodeling
of the enhancer landscape by diet.
Diet Induces a Transcriptional Program Enriched in
Features of Cancer Progression
To assess whether the observed alterations in active enhancer
profile were reflected in the transcriptional program, we per-
formed gene expression microarray analysis. Initial analysis
of the data included determination of expression value and
ANOVA analysis of differentially expressed genes within gender
(Tables S3A and S3B). Gene ontology and pathway analysis
indicated similarities in the pattern of genes responsive to diet
across gender (Tables S3C and S3D). We focused detailed
analysis on the expression data obtained from females.
Consistent with the ChIP-seq, we observed that targets of the
RAS, PI3K, and JNK signaling pathways were upregulated
(Figure S2B), suggesting that differentially enriched H3K27ac re-
gions are biologically functional and drive a specific transcrip-
tional program in colonic epithelia cells. In line with the GREAT
analysis, genes dysregulated by high-fat diet were connected
to inflammation, cancer, cellular movement, and tissue develop-
ment (Figure S4A and Tables S3C and S4A).
Since the epigenomic remodeling by diet resembled the
enhancer signature of colon cancer, we asked whether the re-
sulting gene expression profile also recapitulated gene expres-
sion profiles in colon cancer. Among the most differentially
expressed genes, approximately half were also dysregulated
in mouse colon tumor samples when compared with normal
colon (Figure S3A). To determine whether the gene expression
changes induced by high-fat diet are relevant to human colo-
rectal cancer, we compared differentially expressed genes in
our study to colorectal cancer data sets in Oncomine. We eval-
uated the top 20 genes most highly up- and downregulated
in our study across six different tumor/normal data sets (Fig-
ure S3B); the majority were changed in the same direction as
by diet when comparing cancer with normal colon (Figure 3A).
To ascertain whether the gene signatures induced by high-fat
diet associate with particular features of colorectal cancer, weFigure 3. Diet-Induced Gene Signatures in Colonic Epithelium Are Sig
(A) The top 20most up- (left) and downregulated (right) genes in wild-typemice we
normal colon, rectum, and colon cancer.
(B) Colorectal cancer features enriched in the upregulated genes induced by die
(C) Gene set enrichment analysis using signature genes of CCS3 subtype and ste
score comparing WT HF versus WT LF. ES, enrichment score. NES, normalized
Cperformed Oncomine concepts analysis (http://oncomine.org).
Strikingly, the upregulated genes significantly associated with
gene signatures characterizing the progression of colorectal
cancer to advanced stages (Figure 3B), with enrichment in func-
tions pertinent to tumor invasion and migration (Table S3D). In
keeping with the identification of the RAS and PI3K signaling
pathways (Figure 2B) and the upregulation of their target genes
(Figure S2B), the upregulated gene signature significantly over-
lapped with gene signatures in KRAS mutant tumors and phos-
phatase and tensin homolog (PTEN) mutant cell lines (Figure 3B).
Accordingly, we also observed significant overlap with gene
signatures in cell lines sensitive to inhibitors of these pathways
(Figure 3B and Table S3E). However, concepts discriminating
colon cancer from normal colon were associated only with
downregulated genes at a marginal significance (Table S3E).
Finally, we performed gene set enrichment analysis, asking
whether genes dysregulated in colonic epithelial cells are
enriched with signature genes classifying colorectal cancer
(De Sousa E Melo et al., 2013; Sadanandam et al., 2013). We
observed significant enrichment with signature genes of the
poor-prognosis CCS3 category (De Sousa E Melo et al., 2013)
and the stem-like category (Sadanandam et al., 2013) in the
high-fat-diet-induced differentially expressed genes (Figure 3C),
demonstrating that the gene expression signature induced
by diet is complex, with features consistent with a loss of differ-
entiated status and other features associated with colorectal
cancer progression.
To validate the specific correlation of gene expression alter-
ations by high-fat diet with colon cancer, we also performed
comparison with gene expression in colon of a mouse model
of inflammatory bowel diseases (IBD) at both early and late
inflammation stages (Russ et al., 2013), showing no correlation
with IBD gene expression (Figure S3C).
Obesity, Not Diet, Drives Remodeling of the Enhancer
Landscape
Our results suggest that remodeling of the enhancer landscape
by diet and obesity affects critical genes and pathways impor-
tant for intestinal homeostasis and may render colonic epithe-
lium prone to cancer. It is unclear from any of the above analyses
whether the altered landscape results from direct exposure of
the colonic epithelia to the contents of the lumen or whether
the status of the organism (i.e., obesity) drives the process. To
distinguish between these possibilities, we employed transgenic
mice (females only) expressing human NAG-1/GDF15 (nonste-
roidal anti-inflammatory drug [NSAID]-activated gene-1) (Baek
et al., 2006; Eling et al., 2006). NAG-1 transgenic animals,
when placed on an identical high-fat diet, failed to gain weight
in the same manner as their wild-type counterparts (Figure 4A)
and had a lower ratio of fat mass to body weight (Figure 4B).
We reasoned that these animals would provide us with a suitable
system to ask whether exposure to the colon contents resultingnificantly Enriched with Gene Features in Human Colorectal Cancer
re identified. Heatmaps display the expression profiles of those genes in human
t in wild-type female mice using Oncomine concepts analysis.
m-like subtype as gene sets. Genes in our study were ranked by Signal2Noise
enrichment score. See also Figure S3 and Table S3.
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colonic enhancer program.
We first assessed the impact of the transgene on the gene
expression alterations induced by diet. A heatmap was gener-
ated displaying genes exhibiting diet-induced dysregulation in
wild-type animals with the same genes displayed from NAG-1
transgenic animals (Figure 4C). The transgenic mice displayed
a pattern of expression of these genes that completely differed
from wild-type mice (Figures S4A and S4B and Table S4), sug-
gesting a dominant role of obesity in directing the alterations
in transcriptional program. Comparison of H3K27ac ChIP-seq
data collected from wild-type and NAG-1 transgenic animals
(Figure 4D) demonstrated that loci with significant gains in acet-
ylation in wild-type animals had, on average, no diet-induced
change in acetylation level in the NAG-1 transgenic animals.
Likewise, loci losing acetylation in wild-type animals were un-
changed in the high-fat/low-fat comparison in their transgenic
counterparts. These results suggested that obesity, not diet,
may be the driving factor in altering the epigenomic landscape
in the colons of these mice.
Obesity is closely linked to chronic inflammation, also a hall-
mark of cancer. Consistent with this notion, expression of inflam-
matory cytokines in colon tissue was elevated in a diet-specific
manner in wild-type, but not transgenic, animals (Figure 4E). His-
topathologic examinationof colon tissue revealed thepresenceof
substantial macrophage infiltration in wild-type, but not in NAG-1
transgenic animals on high-fat diet (Figure 4F). To exclude the
possibility thatNAG-1 transgenicmice aredefective in fat absorp-
tion, we performed the steatocrit test with feces from either WT
mice or NAG-1 mice on high-fat diet. NAG-1 transgenic mice
did not show malabsorption of fat (Figure S4C). These data
demonstrate that NAG-1 transgenic mice were resistant to both
the molecular alterations and phenotypes induced by high-fat
diet, suggesting that they result from obesity, not diet per se.
DISCUSSION
During intestinal tumorigenesis, the epithelial cells undergo
dedifferentiation and acquire stem cell-like properties (Schwi-
talla et al., 2013); therefore, colon cancer cells lose enhancer
marks that typify normal crypt differentiation status while
acquiring enhancer marks that are normally found in noncolon
cell types (Akhtar-Zaidi et al., 2012). The differentially acetylated
regions described here were enriched with binding sites of tran-
scription factors downstream of signaling pathways commonly
disturbed in colon cancer and also binding sites of transcriptionFigure 4. Obesity Drives Alterations in Enhancer Landscape in Colon
(A) Body weight of mice on either low-fat diet or high-fat diet (n = 6 for all groups
(B) The column graph depicts the ratio of abdominal fat mass to body weight in m
mean ± SEM.
(C) The heatmap depicts expression of genes dysregulated in wild-type mice by
(D) Diet-induced enhancer alterations were not observed in NAG-1 transgenic mi
and lost H3K27ac regions as identified in the wild-type samples by high-fat diet t
(defined as the 2nd percentile in the distribution of RPKM scores for peaks called i
5th and 95th percentiles; the black dot is the median, and the yellow dot is the m
(E) The column graphs depict quantitative RT-PCR analysis of the indicated infla
were normalized to b-actin. Data are presented as mean ± SEM.
(F) Immunohistochemistry staining of macrophage marker F4/80 reveals that high
also Figure S4 and Table S4.
Cfactors essential for colon development. These findings suggest
that alterations in the H3K27 acetylation program induced by
obesity may reflect both the loss of activities integral to normal
colon homeostasis in addition to gain of activity downstream of
signaling pathways activated in cancer. Although diet induced
alterations in the landscape of H3K27 acetylation, most changes
were not readily associated with alterations in expression of
a linked gene. This finding implies that the enhancer alterations
described here may reflect subtle changes that prime the
genome to respond to a subsequent event.
In the absence of oncogenic stimuli, the occurrence of
obesity-associated cancer was not increased by high-fat diet
in wild-type mice maintained in a specific pathogen-free (SPF)
environment (Yoshimoto et al., 2013). However, following treat-
ment with azoxymethane or via introduction of mutant APC,
mice on a high-fat diet had an incidence of colon tumors higher
than that of mice fed normal chow (Moghaddam et al., 2007;
Reddy et al., 1977; Tuominen et al., 2013). In our study, obesity
induced widespread remodeling of the acetylation landscape at
presumptive cis-regulatory regions that likely influence the tran-
scriptional response suggestive of cancer predisposition. The
associated gene expression profile was specifically enriched in
genes implicated in cancer progression. These data suggest
that a premalignant lesion in the colon from obese individuals
has an increased probability of evolving into a clinically detect-
able malignancy, in part due to priming of the enhancer land-
scape for cancer progression.
EXPERIMENTAL PROCEDURES
Mice
Female h-NAG-1 transgenic mice and wild-type C57BL/6J mice at 5 weeks of
age from a colony known to be positive for Helicobacter were placed on either
10% fat diet (D12450B) or 60% fat diet (D12492, Research Diets) for 20 weeks.
Male C57BL/6J mice on either 10% fat diet (380056 DIO controls) or 60% fat
diet (380050 DIO high-fat diet) for 15 weeks were purchased from Jackson
Laboratory and acclimated for one additional week. All animal experiments
were approved by the NIEHS Institutional Animal Care and Use Committee
and were performed according to NIH guidelines for the care and use of
laboratory animals.
Isolation of Colonic Epithelial Cells
Colonic epithelial cells were isolated as previously described (Roediger and
Truelove, 1979). See also Supplemental Experimental Procedures.
ChIP Sequencing and Data Analysis
Standard crosslinked ChIP DNA was used to construct sequencing
libraries, which were processed as single-end 36-mers (detailed methods in). Error bars represent SE.
ice on either low-fat or high-fat diet (n = 3 for all groups). Data are presented as
diet adjacent to the same genes in NAG-1 transgenic mice.
ce. The reads per kb per million (RPKM) fold change was calculated for gained
reatment, with a floor for the ratio denominator set at the estimated noise level
n nonself samples). The box is the 25th–75th percentile, and the whiskers are the
ean. Grey circles are points beyond the 5th/95th percentiles.
mmatory cytokines in colon tissue (n = 3 for all groups). The expression levels
-fat-diet-induced inflammation was suppressed in NAG-1 transgenic mice. See
ell Metabolism 19, 702–711, April 1, 2014 ª2014 Elsevier Inc. 709
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Obesity Primes Colon Enhancer Landscape for CancerSupplemental Experimental Procedures). ChIP data were filtered for quality
score, aligned, and deduplicated (methodology is detailed in Supplemental
Experimental Procedures). Peaks were assigned by SICER (Zang et al., 2009),
regions of differentially enriched H3K27ac were identified using the diffBind
(v.1.6.2) R package, andmotifs were extracted with HOMER (Heinz et al., 2010).
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus (GEO) accession number for the ChIP-
seq data reported in this paper is GSE46478, and the GEO accession number
for the expression microarray data is GSE46843.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.03.012.
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